Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Committee

Continued Petitions

Myalgic Encephalomyelitis (Treatment) (PE1690)

Thursday 24 January 2019 Public Petitions Committee About 10:15–11:15 Petitions 52 contributions · 10 speakers

Speakers

Choose an MSP to read only their contributions

The record

52 contributions
Johann Lamont Lab The Convener · Glasgow
link

The final petition for consideration is PE1690, which was lodged by Emma Shorter, on behalf of #MEAction Scotland, on the review of treatment of people with myalgic encephalomyelitis in Scotland. I welcome back Emma Harper MSP and Mark Ruskell MSP for consideration of the petition.

In previous written and oral evidence, we have heard concerns about the consistency of treatment for ME sufferers across health boards, about the training and education materials, about the efficacy of cognitive behavioural therapy and graded exercise therapy, and about the level of investment in biomedical research that the Scottish Government announced recently.

Recent written submissions have been included in our meeting papers, and a further submission that has been received from #MEAction Scotland has been provided for members for this morning’s meeting. The Cabinet Secretary for Health and Sport is accompanied by the chief medical officer and Elizabeth Sadler.

I invite the cabinet secretary to make a brief opening statement before we move to questions.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

Thank you very much, convener. I am grateful for the opportunity to contribute to the committee’s consideration of the petition on ME.

Our written submission of 12 July last year sets out in comprehensive terms our response to each of the points that have been raised by the petitioner. I am happy to answer any questions that the committee might have on the matter.

I start by making a fairly fundamental but important point to people who live with ME, which is that I believe you. I believe that ME is a disease that limits the quality of your life, I hear what you are saying to us, and your experience matters to me, as the cabinet secretary.

Yesterday, I was pleased to meet the petitioner, Emma Shorter, and her mother, Janet Sylvester, to hear at first hand the impact that ME has on Emma’s life and on the life of her mother, as her carer. Although we had limited time in the meeting, it was very helpful to me and I assure the committee that I want to make progress and to make life better for people such as Emma who live with the condition.

However, in order to make progress, we must recognise the position from which we are starting. There is clearly a lack of evidence about what causes ME and, from that, how to treat ME. We need more research into the condition. The only way to build an evidence base that can inform treatment options and the development of service is by enhancing the research base. The Government does not initiate research, but we can and will work with the ME community to try to enhance the research base.

Over the past 18 months, we have been developing Scotland’s first national action plan on neurological conditions in co-production with partners and stakeholders, including people who live with neurological conditions, their carers and their families. The five-year plan is wide ranging and has been welcomed by Scotland’s neurological community. We have engaged with the ME community and feedback has been considered by our national advisory committee during the draft plan’s development. Given that the plan is broad and aims to make improvements for everyone who lives with a neurological condition, it does not include condition-specific measures. However, we will continue to take on board any feedback that we receive through the consultation process. The consultation is open until 8 February, and I encourage people to continue to participate in shaping the final plan.

We will continue to work closely with others, including the third sector, to support the work that they do for people who live with ME. In recent years, we have invested just under £0.5 million in funding towards that purpose.

I look forward to taking questions from the committee on the three main areas of the petition.

10:45

Johann Lamont Lab The Convener · Glasgow
link

Thank you very much, cabinet secretary. I am sure that the petitioner very much appreciated the opportunity to speak to you directly. Members of the committee have had representations from people who have ME. My sense is that they have a very strong feeling of not being believed and, as a consequence, being given treatments that make things worse and compound the already challenging circumstances in which they find themselves.

You mentioned the national action plan that was recently published by the national advisory committee for neurological conditions but, as the petitioners note, there is no data on the current prevalence of ME in Scotland. Do you believe that the national action plan can be relevant to people with ME, given that there is such a lack of data and a lack of understanding of the illness among neurologists?

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

I think that the current draft action plan could be enhanced by the contribution that #MEAction and people who live with ME could make to the consultation, which would help us to understand better what those individuals need from the action plan. I completely take their point about the absence of data and research on the subject, but the action plan is not designed to be specific to any particular neurological condition. It aims to identify a common set of actions that should be taken that would assist people who live with a neurological condition, regardless of what the condition is.

As the action plan is developed, I would expect people who live with ME to say, “That set of actions is fine and it works for us, but you’ve missed these other needs that are specific to us.” We would want to look at that and to work with them to see what more we need to do.

As the petitioner and I recognise, there is an absence of research. We might want to look at what more the Government could do in that regard. The absence of data means that it is right that we should work on the basis of the lived experience of ME sufferers. That is why, in addition to the very brief meeting that I had yesterday and further such discussions, I need to hear from ME sufferers so that they can input into the consultation on the draft action plan.

Ms Sadler has a couple of points to add.

Elizabeth Sadler
link

The data on the number of people with neurological conditions that is included in the draft action plan was taken from Information Services Division data, and we absolutely recognise that it is not complete and does not include people with ME. There is a specific commitment in the plan that is about improving the range and depth of data on the number of people affected.

From other sources, we estimate that there are around 20,000 to 21,000 people in Scotland with ME, so it is a disease that is prevalent across the country. The ME community has been very active in engaging with the development of the plan. For instance, we did some work on a lived experience survey with the Health and Social Care Alliance Scotland, and 33 per cent of the responses to that survey were from people with ME. We are seeking people’s views and we are committed to improving the data on the number of sufferers, which could potentially be followed up by research.

Johann Lamont Lab The Convener · Glasgow
link

We are talking about a condition that I was aware of 30 years ago. There was a lot of scepticism and a lot of unhelpful commentary on it in the 1980s. I worked with a colleague who had the condition, and it was evident to me that it was a significant problem. Why is it the case that, 30 years on, ME sufferers are almost still at the point of proving that they exist, because they do not appear in the data?

Dr Calderwood
link

Like the convener, I first came across people with ME a long time ago—in my case, as a junior doctor in Glasgow, when I did a regular clinic at Ruchill hospital in Maryhill. It was very clear to me then that ME was a condition that was highly debilitating.

ME is a very complex condition. The World Health Organization defines it as a neurological condition, but it is a diagnosis of exclusion. People come forward with a wide range of symptoms including nausea and dizziness. Extreme fatigue is always present, which is not helped by any amount of sleep or rest. People can experience muscle pain, and in extreme cases people do not have enough energy to get out of the house. The range of effects on the person’s life is also wide. In the most severe cases, people can be bed bound, have extreme sensitivity to light and noise and have an extremely poor quality of life. Others are able to work and manage their illness.

In scientific terms, ME is somewhat unusual in that there is no test, because there are no biological markers. We cannot do a blood test or an imaging test that will come back with a report saying, “This person has ME,” and therein lies much of the issue. I think that that is why, in the many years since the convener and I first had contact with people with this very real and very debilitating condition, things have not moved on.

We have no means of diagnosing ME except by exclusion, and we have no cure. We do not have a mechanism by which we can create medication or find a treatment through the usual modality in medicine. Because we do not know the cause, we do not have a way of researching how a cure could best be found. The literature across the world shows that that is being struggled with. In Australia, a committee is grappling with similar issues to the ones that the petitioner describes. In the US and other countries, the issue that the convener mentioned is prevalent—the fact that there seems not to be recognition of the condition.

We are talking about something that we have been aware of for many decades without, it would appear, making much progress. I hope that, given the issues that the petitioner has highlighted, we in Scotland may be able to start to move forward rather than saying that this is something that cannot be done.

Maurice Corry Con West Scotland
link

Cabinet secretary, will you ensure that adequate resources are made available to the information gathering group so that we get as much data as possible on the prevalence of ME in Scotland and to ensure that no stone is left unturned?

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

Yes, we will. As Ms Sadler said, the draft action plan contains a commitment to improve data collection and the sources of data. When the draft action plan becomes a plan, the commitments in it will be resourced.

Maurice Corry Con West Scotland
link

So that will follow on from the draft plan. You will make that commitment to make sure that it gives the end results that we are looking for.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

Well, to make sure that it produces improved data.

Angus MacDonald SNP Falkirk East
link

My question is also about resources and your plan to enhance the research base. Will the Scottish Government provide funding for a patient-led national ME strategy to address the issues that have been raised in the petition and in the evidence that we have seen to date?

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

There are a number of factors. First, as I understand the issues that the petitioner raises, and from the brief opportunity that I had yesterday to have the personal conversation that I mentioned, there are issues to do with what can be done to enhance the research base.

I will pick up on Dr Calderwood’s point about ME being a diagnosis of exclusion. We must ask what research can be done to move away from that and see whether there are other ways of reaching a diagnosis and treating the condition. Along with Dr Calderwood and the chief scientist office, which, as we heard, is part of her locus in the Scottish Government, I am very committed to looking at how we might enhance the existing research base, which must include reaching beyond Scotland. As Dr Calderwood has said, other countries are grappling with similar issues, so we need to connect with where they are and what they are discovering so that we can enhance what we have.

However, along with the people who are living with ME, we also need to look at the care and support that they require. We should not wait until we have a better research base and greater clarity on what treatment options might be appropriate. People are living with ME right now, so we need to look at the work that needs to be done to increase awareness and understanding of the condition and, from that, the care and support that sufferers need. We want to work with #MEAction Scotland and others to understand better what needs to be done and then to put it in place.

I am not sure whether that completely answers your question, Mr MacDonald. I guess that I am saying that I need to know what we need to do, and then we will bring to bear the resources to ensure that it happens.

Angus MacDonald SNP Falkirk East
link

You are not ruling out funding for a patient-led national ME strategy.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

No, I am not. I hope that committee members know that I am very committed to the importance of lived experience in contributing to our thinking, policy development and understanding across a range of issues that we need to look at. It is not exclusive, but it is a very important element in this area, in which we have a significant body of patient-led experience to work from.

Brian Whittle Con South Scotland
link

The petitioner has expressed concern that some health boards continue to offer graded exercise therapy and cognitive behavioural therapy as treatments for people with ME, despite there being little evidence that CBT is effective for it. You said that there is an absence of data and that you are having to rely on lived experience. With that in mind, would you consider requesting that such treatments be withdrawn from the published material prior to any review of the NICE guidelines?

Dr Calderwood
link

From my experience in clinics looking after people with ME, it is clear that the illness affects people in a wide range of ways. We have also heard that from the petitioners and we can read about it. I have said that we know that there is not a cure. Perhaps the issue is that some treatments have been deemed to be “the treatment” and therefore suitable for all. Clearly, in some cases such treatment has been continued with despite the patient not finding it to be beneficial or, worse, finding it to be detrimental.

Previously, you and I have talked about realistic medicine. Two of my fundamental principles on that are shared decision making and a personalised approach to care. Let us look at the issue of continuance of any kind of treatment when the patient is telling the practitioner that it is not beneficial and, in fact, is detrimental to them. Why would we continue with that and push somebody into something that clearly, from their experience, is not right for them?

11:00

However, we know from the work of the pilot in Lothian that some of those therapies have been beneficial for some people. That is where I would bring in shared decision making and a personalised approach to care. What is right for one person may not be right for someone in a different situation, so we have to discuss the treatment with people. We would not continue a treatment if it is not right—although I know that that has happened, which is a matter of regret—but some treatments might be helpful for some people, as long as they share in that decision. Therefore, we need to be cautious about withdrawing a particular treatment but, on the other hand, we must not continue with a treatment when it is clearly not right for the individual.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

As I am sure members know, we have the Scottish good practice statement on ME. The guidelines in that statement recognise that some treatments are controversial and they are clear that nobody should be required to have a treatment that they do not want, although, like Dr Calderwood, I recognise that that has not been the case in every circumstance.

That goes back to the earlier point about the need for awareness raising and education among our clinical community to ensure that people know about the Scottish good practice statement on ME, which says clearly that, with ME, as with other matters, treatment decisions should involve the patient, and that patients should not feel compelled to undergo a treatment that they do not want. That is the route that we should pursue. Given the evidence that those controversial treatments produce a benefit for some, rather than withdraw those treatments, we should assert that people should be actively involved in decisions on their treatments and on whether to engage in those treatments.

Brian Whittle Con South Scotland
link

Given the lack of data on and understanding of ME generally across the medical profession, on which we have heard evidence, how can you cascade that approach? We have heard a lot of evidence that some medical practitioners still deny the existence of ME, which must be a terrible experience for an ME sufferer. How do we cascade that approach into front-line services? For me, that has always seemed to be one of the key elements in relation to this issue.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

I will say two things in response to that, and Dr Calderwood may want to add to them.

As there is a lack of sufficient evidence and research, it would not be especially helpful to get involved in an argument between clinicians who recognise ME and those who do not. Considering how we can enhance the research base will assist us in resolving that question. The absence of sufficient research can be used as a reasonable ground for individuals to pursue different arguments in relation to whether they accept that ME exists. I completely understand that people must feel more than frustration if they have the condition but it is not accepted or recognised as a medical condition.

On how we enhance the research base, I have asked the chief medical officer to consult the chief scientist about what more the Scottish Government might do to assist our academic communities to increase the level of research. We have provided initial funding to support a PhD student to begin some work, but we might be able to do more in that regard.

How do we make sure that the good practice statement is more widely understood? With our networks in the clinical community, through the chief medical officer, and with the health board community, through my locus, we need to look at how—alongside the statement of good practice—we increase awareness and understanding in order to reduce the incidence of individuals who feel that they are being compelled to take a treatment that they do not want.

Brian Whittle Con South Scotland
link

Surely, given the length of time that we have been aware of ME, nobody should now deny the existence of the condition. Surely, we cannot accept medical practitioners taking the opposite view. That has to be tackled—it could be tackled right now.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

I ask Dr Calderwood to pick that up.

Dr Calderwood
link

As a result of the petition, and because the statistics show that such a large number of the medical profession—I think that it is up to 50 per cent of general practitioners—do not accept ME as a condition, we undertook to write to Sir Peter Rubin, who is the chair of the board for academic medicine. He has distributed the letter to the deans of Scotland’s medical schools with information highlighting the condition and some of the detail that I gave earlier, so that that is incorporated into the schools’ curriculum. We cannot dictate what they put in their curriculum, but—this is not an immediate solution—teaching our medical students, who are our future doctors, about the condition will change attitudes. That approach has not previously been focused on.

Brian Whittle Con South Scotland
link

For the avoidance of doubt, there is no way that we can say that ME does not exist as a condition; there is no way that we can deny that. If that is the case, surely there must be a way to cascade to front-line staff that it will no longer be acceptable to deny the existence of ME.

Dr Calderwood
link

I confirm that the WHO has a definition of ME/chronic fatigue syndrome; it is a World Health Organization-defined disease.

Brian Whittle Con South Scotland
link

I am sorry to push you on this but, therefore, we cannot accept any of our medical practitioners denying its existence and denying access to treatment.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

This Government absolutely accepts the World Health Organization definition, so we say to practitioners, “The World Health Organization, this Government and NHS Scotland accept that this condition exists, therefore, we expect you, in carrying out your clinical practice, to operate on that basis.” There is no reason why we would not make that crystal clear, and I am very happy to make that crystal clear.

However, as frustrating as it is, we nonetheless all have to accept that it is right that a clinician’s decision—this applies to their views, decision making and how they work with an individual patient across the whole spectrum of medical conditions—cannot be countermanded by me. I cannot instruct them in that regard. I can say what the position is of NHS Scotland and the Government and, therefore, what I expect, but I am not in every clinical situation and consultation.

I can make sure that clinicians are aware of and understand what the statement of good practice says, and that they are aware of our expectation that they will work to that statement of good practice. We will then look at how we can support individual patients, including when they express their rights not to undergo treatment that they do not wish to undergo.

There are a number of ways of going about this, but I cannot issue an instruction to clinicians.

Brian Whittle Con South Scotland
link

I am sorry to push you again. I absolutely accept that you would never countermand any medical diagnosis or treatment, but I am making the point that we cannot have medical practitioners who, before treatment, deny the existence of ME. That is what I am getting at, and I want to ensure that we can do something positive about that.

Dr Calderwood
link

Regardless of what a medical practitioner believes, if somebody presents with those symptoms, they need treatment and help with those symptoms. We would be able to say that the list of symptoms that I have discussed are symptoms that need to be treated. Some of the frustration that petitioners and medical practitioners feel comes about because the range of treatment options is limited and their knowledge of the treatment options that might be best is limited. If they then want to access some treatment, they find that it is available in some places and not in others.

Regardless of that practitioner’s opinion, if I can put it that way, about a WHO-defined disease, the people who are suffering from the illness need help, and we need to get to the point at which appropriate help that is individualised to them as a patient in their situation is made available to them. It is clear that that is not the case in Scotland at the moment.

Johann Lamont Lab The Convener · Glasgow
link

Cabinet secretary, you said that people should not be compelled to undergo treatment, and that is entirely fair. Is there an issue to do with people being judged when they say that they do not want that treatment? We took evidence from Professor Jonathan Edwards and, although I do not want to put words in his mouth, my reading of what he said is that there is almost a false correlation—because people benefit from the treatment, the implication is that ME patients benefit from the treatment, but ME patients are saying that the nature of treatment offered has nothing to do with their condition, and their being compelled, or feeling obliged or under pressure to take CBT or GET action is making things worse. Do you accept that there is an issue to do with people being judged? You might say that they are free to refuse treatment, but that can bring accusations that they would not engage and that they are being reluctant or difficult, and that feeds into that narrative.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

It is credible to me that that situation can arise and, from what I have been advised by those who suffer from ME, it has arisen. That speaks to a lack of awareness and understanding of the condition. You said it yourself, convener: 30 years ago, individuals who suffered from the condition were unfairly characterised, and it is fair to say that some of that unfair characterisation persists.

That relates to one of the areas that the petitioner highlighted—and I accept that we need to do more work on it—about the need to raise awareness and understanding in order to minimise the number of people, be they clinicians or otherwise, who do not believe that there is such a condition, and act on that belief in a way that is unfair and debilitating for the individuals who suffer from the condition.

Although we look to change such attitudes and views, another important point is that, as Dr Calderwood said, when someone with symptoms comes to a clinician, the clinician’s job—regardless of their view on whether ME exists—is to deal with those symptoms, treat the individual and provide that person with whatever care and support they can.

11:15

David Torrance SNP Kirkcaldy
link

Some of the evidence that has been presented to the committee focuses on the investment that the Scottish Government recently announced. The petitioner notes that an investment of £15,000 per year over the next three years equates to 70p per patient. How do you respond to such concerns? Do you consider such investment sufficient to build research capacity?

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

That is the support that we have given a PhD student to begin work on how we might enhance the research base. I believe that #MEAction approached us for that support, which we have given. That does not preclude what I have touched on, which is my request for the chief medical officer and, through her, the chief scientist, to look at how we might further support an enhancement of the research base.

I hope that that investment will not be the only thing that we do. We responded to a request from #MEAction to support the PhD student to do that work, along with Professor Ponting, but that is not the end of the story.

Brian Whittle Con South Scotland
link

Following up our earlier discussion, we agree that there is evidence of a lack of understanding of ME among healthcare professionals, which was identified in the National Advisory Committee on Neurological Conditions report on the lived experience survey. Given that, how will you ensure that NHS Education for Scotland provides effective education and training based on the most up-to-date biomedical research?

Elizabeth Sadler
link

We have given Action for ME money to support the provision of information for health professionals. Its website now hosts a series of materials on good practice, and the organisation provides webinars for shared learning, local models of care and good practice. Action for ME has also worked with NHS inform to put information about ME on the NHS inform website.

NES is developing a training module for GPs to raise awareness and support them. That will be in NES’s next iteration of work, in the next financial year.

Brian Whittle Con South Scotland
link

How do we ensure a positive uptake of training such as webinars and modules?

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

I understand that, when NES considered the issue, it did work through the GP group that it works with on how a training module would be responded to, and the response from GPs was positive—GPs would like that to be available to them. NES is now working on that.

On the basis of the initial positive response that GPs would like such additional training, we expect uptake to be good. However, we always look at how positive any uptake is and what more we might do to encourage GPs to undertake additional training.

Johann Lamont Lab The Convener · Glasgow
link

I am conscious of the time—we need to wrap up by 25 to 12 and we must stop by 20 to 12—so I ask our two colleagues who are not committee members to contribute now, as I am keen to allow them to participate. If there is time left after that, the committee can raise a number of other questions.

Mark Ruskell Green Mid Scotland and Fife
link

Comments have been made about enhancing research. To what extent can the provision of specialist support on the ground help develop the research and fill the gaps in effective support and treatment for people with ME? In Fife, a popular support service has been put in place, but it has become very overstretched. Moreover, those kinds of support services are not being offered across Scotland. How can the roll-out of particular approaches to supporting people with ME enhance the growing knowledge and understanding of how we effectively treat and support people with the condition, as part of a package of research?

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

I will ask Dr Calderwood to answer that question, but before I do, I just want to say that I appreciate the convener’s point about timing. I need to be in the chamber to answer general questions at 20 to 12—I think that I am first up—so I would appreciate it if I could leave soon.

Johann Lamont Lab The Convener · Glasgow
link

Let us try to finish by half past 11. We might have a few more questions to direct to you, but we can send them on to you. I think that that is only fair—-you have more than earned your corn this morning, cabinet secretary. It is a pity that you have to answer the first question at general questions—you are not going to have a rest.

I will take Emma Harper’s questions, then the committee will come to its conclusions instead of asking its final few questions. We will just send them to you.

Jeane Freeman SNP Carrick, Cumnock and Doon Valley
link

Thank you, convener. I appreciate that.

Dr Calderwood
link

Again, I congratulate the petitioner on bringing to the fore this illness, the existence of which has been denied and ignored. It has received neither the provision for treatment nor, as I said in response to David Torrance’s question, the funding for research that other neurological conditions have received. When we pull together what the petitioner has bravely brought forward—I think that some of the people involved are here today—we see that in Scotland we need a co-ordinated approach to tackling the illness of ME.

We therefore propose the creation of a working group to look at the provision of services and consider the good practice in NHS Fife that Mark Ruskell mentioned. We will need to scope out what the asks of the group will be. We know that up to 21,000 people in Scotland have ME, which means that, on average, each GP practice has about 20 patients with the illness. We will also look at the pilot in NHS Lothian, which involved some effective interventions and treatment, and we will bring into the ME working group people who have been involved in good practice in Scotland.

There will be a series of pieces of work, and I can see the scope including the education and awareness raising that Brian Whittle mentioned, the availability and provision of treatment and so on. As I have said, we do not have a cure at the moment. There are some treatments that work, and there are some that clearly do not work for everyone.

As well as all the work that is going on in the background, there will be the enhanced research that I have mentioned. On the research front, we in Scotland will need to join up with others, perhaps on a global scale, given that other countries are struggling with many of the issues that the petitioner has highlighted and are in the same position as we are in. I would not want us to set off on something that is then delayed, because people are suffering. While we wait for the evidence—including the NICE guidance, which is due to be published in 2020—we in Scotland can set up the working group to tackle what issues we can tackle, and that can be done by looking at the good practice that we know works in places such as NHS Fife.

Emma Harper SNP South Scotland
link

I am aware that, in the House of Commons today, there will be a debate led by Scottish National Party MP Carol Monaghan, calling for more funding for biomedical research. Funding from the Westminster and Scottish Governments would be welcome. I will follow that debate and send on any questions later.

Johann Lamont Lab The Convener · Glasgow
link

I thank the cabinet secretary and her colleagues for attending the meeting and for the seriousness with which they have addressed the petitions. We will now consider this particular petition. If the witnesses need to leave, they have permission to do so—if they need it—and I suspend the meeting very briefly to allow that to happen.

11:24 Meeting suspended.

11:25 On resuming—

Johann Lamont Lab The Convener · Glasgow
link

We will now reflect on the evidence that we have heard. I should have said at the beginning of the meeting that I thank all those who provided submissions to the committee. A significant number of people with an interest in the petition responded, and that has helped the committee’s consideration. We will invite the petitioner to respond to today’s evidence from the cabinet secretary and her colleagues, and other people with an interest might want to respond to what they have heard, too.

Do members have any comments or suggestions for actions that they would like the committee to take?

Brian Whittle Con South Scotland
link

First, I would just say that this petition shows the importance of bringing petitions to the committee. As has been very evident today, they raise awareness of such issues, and that, in itself, is helpful.

There are two issues for me: first, how we ensure that research on the treatment of ME continues, and secondly—this is where we could probably have the most impact on right here, right now—how we get over the hurdle of medical practitioners denying the existence of ME. The Government could take some specific actions to address that issue, and we need to look at how the committee can help facilitate that or push such action along.

Emma Harper SNP South Scotland
link

The Royal College of General Practitioners has an online training programme for chronic fatigue syndrome and ME, and it would be interesting to know its uptake by GPs.

Mark Ruskell Green Mid Scotland and Fife
link

To pick up on Brian Whittle’s point, I think that it is a matter of concern that 80 per cent of neurologists still do not consider ME a physical condition. There is a mismatch between what is happening on the ground with regard to treatment and the commitment to research that we have heard from the cabinet secretary and others this morning.

Johann Lamont Lab The Convener · Glasgow
link

The issue of research is significant. An area that we did not focus on is the role of clinical nurse specialists; although the Government describes that role as “pivotal”, there is only one clinical nurse specialist for people with ME in Scotland and none of the additional investment has gone towards nurses for people with ME. We will want to ask the Government about that, but we are conscious of the pressures on the cabinet secretary’s time.

We will ask for a response from the petitioner and anyone else who is interested in the matter. Specifically, we will ask about the GP uptake of the online programme as well as the role of the specialist nurses and whether there is a sufficient number of them. It would also be interesting to know, as Mark Ruskell suggested, about the level of support other than clinical support in the system.

I thank everyone for attending, particularly our visitors Emma Harper and Mark Ruskell. Again, I put on record our appreciation to the Cabinet Secretary for Health and Sport for spending such a significant amount of time with us on these very important petitions, even though that they are a small part of her broad remit.

Thank you all very much. I now close the meeting.

Meeting closed at 11:28.

  1. 09:00 Continued Petitions Petitions · 1
  2. 09:15 Continued Petitions Petitions · 68
  3. 09:45 Continued Petitions Petitions · 84
  4. 10:15 Continued Petitions Petitions · 52

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.